This section is dedicated to preclinical evaluation of molecules with antiviral potential against the SARS-CoV-2. It may receive links to important pu... read more
global Non-profit organisation for sharing viral material within the scientific community
EVA-GLOBAL is an open entity aiming at developing synergies and complementary capabilities
EVA-GLOBAL provides you with high quality viruses and derived products
EVAg is a non profit organisation that mobilises a global network with expertise in virology to collect amplify characterise standardise authenticate distribute track viruses and derived products.
A unique biological resource in the field of virology, readily available online. Users may benefit from special funding to access to products of interest, do not hesitate to apply.
A network of laboratories
An international group of 25 laboratories, including 16 EU member state institutions and 9 non-EU institutions, that represent an extensive range of virological disciplines.
An open entity aiming at developing synergies and complementary capabilities in such a way as to offer an improved access to researchers.
The quality of viruses and derived products is a key consideration when our products are to be made available. Improvements on quality process will be addressed during the project.
Preparedness and Response
EVAg generates and distributes globally diagnostic materials and protocols in the event of epidemiological emergencies.
Focused on the creation of new tools, techniques and concepts to develop the infrastructure and to provide easier and less expensive access to virological materials.
A user-friendly web Portal with a continuously increasing number of viruses and derived products. Start here...
The EVAg initiative will increase competitiveness and, provides for a strong interaction with industry and a promising foundation for the innovation process between academia and industry.- The European Commission -
The initiative has an important social impact with particular emphasis on human disease.- The European Commission -
The quality of the installations cooperating in this consortium is excellent, representing some of the best available infrastructures across the EU and world-wide.- The European Commission -
Our Latest Tweets
CALL FOR CONTRIBUTION: COVID19 antiviral compounds test results https://t.co/IJHwWNJoOA We created this page to SHARE preclinical evaluation of molecules with antiviral potential against the SARS-CoV-2. !!Negative results are important too!! Submission details in link provided https://t.co/tUucpSrsgc
***IMPORTANT*** FLI added to the EVAG catalogue a SARS-CoV-2 recombinant antigen for serological assays ! Order Here FREE OF CHARGE WORLDWIDE: https://t.co/2issU5wVtL Assay described here https://t.co/f05bx7FF27 by @florian_krammer 's team Please share. @Loeffler_News https://t.co/K8vDJfNhvl
@NakedCapsid On a more personal note : management team is based in Marseille, sunny South of France, v. nice group of people, living in an office that we call "the corridor", where we host nice crêpe parties, and eat definately too much chocolate, while wishing we could foster cats there.
@NakedCapsid Hi guys, well, we're a non-profit org, a EU research infrastructure, a biobank distributing viruses and derived products. For free, worldwide. Yes, 2000 viruses on our online catalogue. We've distributed 2200 covid related products in 80 countries in 3 months. Speak soon ;)